Provided By GlobeNewswire
Last update: Aug 15, 2025
Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years
Fibromyalgia is a chronic pain condition that affects more than 10 million adults in the U.S. who are mostly women
Read more at globenewswire.com51.35
-8.23 (-13.81%)
Find more stocks in the Stock Screener